Menu
Biosimilar medicines represent an important advancement in healthcare, offering greater patient access to biological therapies that might otherwise be cost-prohibitive. The biosimilar development process revolves around a comprehensive comparability assessment between the proposed biosimilar and its reference biological product. The primary goal of the development process isn’t to establish the
Discover how supplementing CHO cell cultures with high-quality Recombinant Insulin can improve and stabilize cell culture performance—ultimately driving higher monoclonal antibody (mAb) yields and lowering production costs.
Recombinant insulin enhances CHO-K1 fed-batch culture performance and consistency while reducing costs in cell culture processes.
Scale-up production, optimise processes, and increase cellular products yields with our Recombinant Insulin that’s approved by regulatory bodies worldwide.
Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Novo Nordisk Pharmatech is a leading Benzalkonium Chloride manufacturer. We provide only the best and safest ingredients.
Scale-up production, optimise processes, and increase cellular products yields with our Recombinant Insulin that’s approved by regulatory bodies worldwide.
Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]
CVR-no. 13246149
